CVE:SBM Sirona Biochem (SBM) Stock Price, News & Analysis → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free SBM Stock Alerts C$0.06 0.00 (0.00%) (As of 11:19 AM ET) Add Compare Share Share Today's RangeC$0.07▼C$0.0750-Day RangeC$0.07▼C$0.1252-Week RangeC$0.07▼C$0.22Volume12,000 shsAverage Volume75,440 shsMarket CapitalizationC$16.51 millionP/E RatioN/ADividend Yield1.50%Price TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Sirona Biochem alerts: Email Address Ad WealthPressA lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. Click here to jump in on the next one About Sirona Biochem Stock (CVE:SBM)Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.Read More SBM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SBM Stock News HeadlinesMarch 13, 2024 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum FormulationsMarch 13, 2024 | finance.yahoo.comSirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum FormulationsMarch 28, 2024 | WealthPress (Ad)A lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. February 21, 2024 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Announces Plans for Commercial Launch of GlycoProteMim in Early 2025February 16, 2024 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Provides Update on LoanFebruary 15, 2024 | stockhouse.comSirona Biochem Provides Update on LoanFebruary 15, 2024 | markets.businessinsider.comSirona Biochem Engages Global Beauty ConsultingJanuary 29, 2024 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Announces LoanMarch 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…January 29, 2024 | markets.businessinsider.comSirona Biochem Announces LoanJanuary 26, 2024 | financialpost.comSirona Biochem Initiates Private PlacementJanuary 24, 2024 | stockhouse.comCORRECTION -- Sirona Biochem Corporate Update January 2024January 24, 2024 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Corporate Update January 2024January 24, 2024 | finance.yahoo.comSirona Biochem Corporate Update January 2024January 15, 2024 | financialpost.comSirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories™December 11, 2023 | finance.yahoo.comSirona Biochem Initiates GlycoProteMim™ Trademark for Anti-Aging Molecule TFC-1326December 7, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp down on Thursday (SBM)November 2, 2023 | tmcnet.comSirona Announces Support for SpaceX's Starlink Network, Allowing Radiologists to Practice from AnywhereOctober 20, 2023 | benzinga.comSirona Biochem Announces Payment of Convertible Debenture Interests in SharesOctober 18, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp flat on Monday (SBM)September 30, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp down on Friday (SBM)September 28, 2023 | tmcnet.comSirona Selects Koios, Rad.ai, & RevealDX as Founding AI Partners Ahead of November Launch EventAugust 22, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp up on Monday (SBM)June 28, 2023 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEBJune 28, 2023 | finance.yahoo.comSirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEBMay 25, 2023 | stockhouse.comSirona Biochem Engages Atheln Inc. to Strengthen Business Development InitiativesMay 11, 2023 | finance.yahoo.comSirona Biochem: Investing News Network Interview with CSO, Dr. Geraldine Deliencourt-GodefroySee More Headlines Receive SBM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sirona Biochem and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/28/2024Next Earnings (Estimated)3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:SBM CUSIPN/A CIKN/A Webwww.sironabiochem.com Phone604-641-4466FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-2,540,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-9,810.47% Return on Assets-124.46% Debt Debt-to-Equity Ratio219.21 Current Ratio0.55 Quick Ratio2.41 Sales & Book Value Annual SalesC$683,768.00 Price / Sales24.15 Cash FlowC$0.00 per share Price / Cash Flow35.00 Book ValueC($0.01) per share Price / Book-6.50Miscellaneous Outstanding Shares254,060,000Free FloatN/AMarket CapC$16.51 million OptionableNot Optionable Beta-0.31 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesDr. Howard J. Verrico M.D. (Age 63)Ph.D., Founder, Chairman of the Board, CEO & Secretary Comp: $180.64kMr. Christopher D. Hopton C.G.A. (Age 58)CPA, CFO & Director Comp: $147.84kDr. Géraldine Deliencourt-Godefroy Ph.D.Chief Scientific Officer & DirectorKey CompetitorsCeaproCVE:CZOReunion NeuroscienceTSE:REUNNeptune Wellness SolutionsTSE:NEPTResverlogixTSE:RVXLiberty BiopharmaCVE:LTYView All Competitors SBM Stock Analysis - Frequently Asked Questions How have SBM shares performed in 2024? Sirona Biochem's stock was trading at C$0.12 at the start of the year. Since then, SBM stock has decreased by 45.8% and is now trading at C$0.07. View the best growth stocks for 2024 here. When is Sirona Biochem's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 28th 2024. View our SBM earnings forecast. What other stocks do shareholders of Sirona Biochem own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sirona Biochem investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP). How do I buy shares of Sirona Biochem? Shares of SBM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:SBM) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sirona Biochem Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.